5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole

C98H125B2Cl3IN33O10 — CID 167532329

IUPAC5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
SMILESCC1(C)OB(c2ccnn2C2CCCCO2)OC1(C)C.C[C@@H]1COCCN1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)n2ncc(-c3ccnn3C3CCCCO3)c2n1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)n2ncc(I)c2n1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)n2nccc2n1.Clc1cc(Cl)n2nccc2n1.Cn1nccc1-c1cc(Cl)nc2ccnn12.Cn1nccc1B1OC(C)(C)C(C)(C)O1
InChIInChI=1S/C23H28N8O2.C15H17IN6O.C15H18N6O.C14H23BN2O3.C10H17BN2O2.C10H8ClN5.C6H3Cl2N3.C5H11NO/c1-16-15-32-12-10-29(16)21-13-20(19-7-8-24-28(19)2)31-23(27-21)17(14-26-31)18-6-9-25-30(18)22-5-3-4-11-33-22;1-10-9-23-6-5-21(10)14-7-13(12-3-4-17-20(12)2)22-15(19-14)11(16)8-18-22;1-11-10-22-8-7-20(11)15-9-13(12-3-5-16-19(12)2)21-14(18-15)4-6-17-21;1-13(2)14(3,4)20-15(19-13)11-8-9-16-17(11)12-7-5-6-10-18-12;1-9(2)10(3,4)15-11(14-9)8-6-7-12-13(8)5;1-15-7(2-4-12-15)8-6-9(11)14-10-3-5-13-16(8)10;7-4-3-5(8)11-6(10-4)1-2-9-11;1-5-4-7-3-2-6-5/h6-9,13-14,16,22H,3-5,10-12,15H2,1-2H3;3-4,7-8,10H,5-6,9H2,1-2H3;3-6,9,11H,7-8,10H2,1-2H3;8-9,12H,5-7,10H2,1-4H3;6-7H,1-5H3;2-6H,1H3;1-3H;5-6H,2-4H2,1H3/t16-,22?;10-;11-;;;;;5-/m111....1/s1
InChIKeyADHSKNSYKNSSHR-DHVSZTIMSA-N
MW2180.19 g/mol
LogP12.65
Rot. Bonds12

About 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole

5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole (PubChem CID 167532329) has the molecular formula C98H125B2Cl3IN33O10 and a molecular weight of 2180.19 g/mol. Its IUPAC name is 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole.

Molecular Properties

Compound Name5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
PubChem CID167532329
Molecular FormulaC98H125B2Cl3IN33O10
Molecular Weight2180.19 g/mol
Exact Mass2177.86
IUPAC Name5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
SMILESCC1(C)OB(c2ccnn2C2CCCCO2)OC1(C)C.C[C@@H]1COCCN1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)n2ncc(-c3ccnn3C3CCCCO3)c2n1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)n2ncc(I)c2n1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)n2nccc2n1.Clc1cc(Cl)n2nccc2n1.Cn1nccc1-c1cc(Cl)nc2ccnn12.Cn1nccc1B1OC(C)(C)C(C)(C)O1
InChIInChI=1S/C23H28N8O2.C15H17IN6O.C15H18N6O.C14H23BN2O3.C10H17BN2O2.C10H8ClN5.C6H3Cl2N3.C5H11NO/c1-16-15-32-12-10-29(16)21-13-20(19-7-8-24-28(19)2)31-23(27-21)17(14-26-31)18-6-9-25-30(18)22-5-3-4-11-33-22;1-10-9-23-6-5-21(10)14-7-13(12-3-4-17-20(12)2)22-15(19-14)11(16)8-18-22;1-11-10-22-8-7-20(11)15-9-13(12-3-5-16-19(12)2)21-14(18-15)4-6-17-21;1-13(2)14(3,4)20-15(19-13)11-8-9-16-17(11)12-7-5-6-10-18-12;1-9(2)10(3,4)15-11(14-9)8-6-7-12-13(8)5;1-15-7(2-4-12-15)8-6-9(11)14-10-3-5-13-16(8)10;7-4-3-5(8)11-6(10-4)1-2-9-11;1-5-4-7-3-2-6-5/h6-9,13-14,16,22H,3-5,10-12,15H2,1-2H3;3-4,7-8,10H,5-6,9H2,1-2H3;3-6,9,11H,7-8,10H2,1-2H3;8-9,12H,5-7,10H2,1-4H3;6-7H,1-5H3;2-6H,1H3;1-3H;5-6H,2-4H2,1H3/t16-,22?;10-;11-;;;;;5-/m111....1/s1
InChIKeyADHSKNSYKNSSHR-DHVSZTIMSA-N
XLogP12.65
TPSA389.74 Ų
H-Bond Donors1
H-Bond Acceptors43
Rotatable Bonds12
Heavy Atoms147
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002180.19
LogP ≤ 512.65
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
The IUPAC name of 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole (CID 167532329) is 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole.
What is the SMILES notation for 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
The canonical SMILES for 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole is CC1(C)OB(c2ccnn2C2CCCCO2)OC1(C)C.C[C@@H]1COCCN1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)n2ncc(-c3ccnn3C3CCCCO3)c2n1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)n2ncc(I)c2n1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)n2nccc2n1.Clc1cc(Cl)n2nccc2n1.Cn1nccc1-c1cc(Cl)nc2ccnn12.Cn1nccc1B1OC(C)(C)C(C)(C)O1.
What is the InChIKey of 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
The InChIKey is ADHSKNSYKNSSHR-DHVSZTIMSA-N. The full InChI is InChI=1S/C23H28N8O2.C15H17IN6O.C15H18N6O.C14H23BN2O3.C10H17BN2O2.C10H8ClN5.C6H3Cl2N3.C5H11NO/c1-16-15-32-12-10-29(16)21-13-20(19-7-8-24-28(19)2)31-23(27-21)17(14-26-31)18-6-9-25-30(18)22-5-3-4-11-33-22;1-10-9-23-6-5-21(10)14-7-13(12-3-4-17-20(12)2)22-15(19-14)11(16)8-18-22;1-11-10-22-8-7-20(11)15-9-13(12-3-5-16-19(12)2)21-14(18-15)4-6-17-21;1-13(2)14(3,4)20-15(19-13)11-8-9-16-17(11)12-7-5-6-10-18-12;1-9(2)10(3,4)15-11(14-9)8-6-7-12-13(8)5;1-15-7(2-4-12-15)8-6-9(11)14-10-3-5-13-16(8)10;7-4-3-5(8)11-6(10-4)1-2-9-11;1-5-4-7-3-2-6-5/h6-9,13-14,16,22H,3-5,10-12,15H2,1-2H3;3-4,7-8,10H,5-6,9H2,1-2H3;3-6,9,11H,7-8,10H2,1-2H3;8-9,12H,5-7,10H2,1-4H3;6-7H,1-5H3;2-6H,1H3;1-3H;5-6H,2-4H2,1H3/t16-,22?;10-;11-;;;;;5-/m111....1/s1.
What are the key properties of 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole has a molecular weight of 2180.19 g/mol, XLogP of 12.65, 12 rotatable bonds, 1 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;5,7-dichloropyrazolo[1,5-a]pyrimidine;(3R)-4-[3-iodo-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-3-methylmorpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)-3-[2-(oxan-2-yl)pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methyl-4-[7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;(3R)-3-methylmorpholine;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1-(oxan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole is sourced from PubChem (CID 167532329), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).